A Randomized Double-Blind Trial of the Effect of Liupao Tea on Metabolic Parameters, Body Composition, and Gut Microbiota in Adults with Metabolic Syndrome
Nutrients · 2025
DOI: 10.3390/nu17142371 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Yuyang Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Social Medicine and Health Education, School of Public Health, Peking University Health Science Center, Beijing 100191, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Body Composition, Metabolic Syndrome, Tea. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Metabolic syndrome (MetS) represents a significant global health challenge. Liupao tea (LPT), a post-fermented dark tea, has shown potential metabolic benefits, but clinical evidence remains limited.
Objectives
This study aimed to investigate the effects of LPT with varying aging durations on clinical parameters, body composition and gut microbiota in individuals with MetS.
Methods
In a randomized, double-blind trial, patients with MetS were randomly assigned to intervention groups, receiving 6 g/day of LPT aged for 1, 4, 7, or 10 years, respectively, over a 90-day intervention period. Blood pressure, lipid and glucose levels, body weight, body composition, and gut microbiota were assessed at baseline and post-intervention.
Results
A total of 71 participants, with a mean age of 53.5 years, were included. At the final assessment, significant reductions in both systolic and diastolic blood pressure were observed in the 10-year-aged groups (p < 0.05). In terms of lipid profiles, the 1-year-aged group showed a significant decrease in total cholesterol (TC), while low-density lipoprotein cholesterol (LDL-C) levels significantly decreased in the 1-, 4-, 7-, and 10-year-aged groups (p < 0.05). All intervention groups showed significant reductions in body weight, body fat mass (BFM), along with an increase in muscle mass (MM) (p < 0.05). A decrease in the Firmicutes/Bacteroides (F/B) ratio was observed in the 10-year-aged group. No significant differences in clinical parameters or body composition regulation were observed between groups with varying aging durations (p > 0.05).
Conclusions
LPT intervention effectively improves metabolic health and modulates gut microbiota in MetS patients, irrespective of aging duration. These findings support LPT as a functional beverage for the management of MetS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Social Medicine and Health Education, School of Public Health, Peking University Health Science Center, Beijing 100191, China.
- Zhaoping Tea Science and Technology Courtyard, Zhaoping, Hezhou 546800, China.
ORCID-Profile: Yuyang Wang, Qiang Hu, Defu Ma
Zitieren
APA
Wang, Y., Hu, Q., Jiang, Q., Jiang, J., Li, B., & Ma, D. (2025). A Randomized Double-Blind Trial of the Effect of Liupao Tea on Metabolic Parameters, Body Composition, and Gut Microbiota in Adults with Metabolic Syndrome. Nutrients. https://doi.org/10.3390/nu17142371
Vancouver
Wang Y, Hu Q, Jiang Q, Jiang J, Li B, Ma D. A Randomized Double-Blind Trial of the Effect of Liupao Tea on Metabolic Parameters, Body Composition, and Gut Microbiota in Adults with Metabolic Syndrome. Nutrients. 2025. doi:10.3390/nu17142371
BibTeX
@article{Wang2025,
author = {Wang, Yuyang and Hu, Qiang and Jiang, Qiliu and Jiang, Jiamin and Li, Biandi and Ma, Defu},
title = {A Randomized Double-Blind Trial of the Effect of Liupao Tea on Metabolic Parameters, Body Composition, and Gut Microbiota in Adults with Metabolic Syndrome},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17142371}
}
EUVIMED